ANP 0.00% 11.0¢ antisense therapeutics limited

Hi Itsa, if the trial in DMD goes well, it will be...

  1. 737 Posts.
    lightbulb Created with Sketch. 486
    Hi Itsa,
    if the trial in DMD goes well, it will be commercialised.
    If there are 26000 boys in the EU and being conservative we look at 50% being nonambulant, and then we were to get 50% of those boys being treated with ATL-1102 there would be 6500x$100,000 which equals $650m
    If we took $150m expenses to earn $650 it would leave about $500m profit.
    With a conservative PE of only x10 that would have the share price at approx $5.00

    This is all back-of-napkin conversation, and all erring on the very conservative side and doesn't include the US or other non-EU regions.
    It doesn't include any other indications or ailments, just non-ambulent DMD EU boys.
    It also doesn't focus on ramp up or also down, it's a generic median.

    Loose discussion but indicative.
 
watchlist Created with Sketch. Add ANP (ASX) to my watchlist
(20min delay)
Last
11.0¢
Change
0.000(0.00%)
Mkt cap ! $73.56M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0
ANP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.